That’s because it’s been five years since recommendations began changing about who should take the tiny little pill to prevent heart problems, and new data shows that 48% of adults still mistakenly ...

nevertheless, there was a small but statistically significant increase in major GI bleeding (47 [0.4%] vs 29 [0.2%]; p = 0.04) with high-dose versus low-dose aspirin.

As low-dose prophylactic aspirin therapy becomes common among older people, potential risks that are associated with such treatment assume increasing importance. In particular, some clinicians are ...

aDivision of Hematology and Hematological Malignancies, Department of Medicine, University of Calgary, Calgary, AB, Canada bDepartment of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine ...

Results from the STEP UP trial show that a high-dose formulation of Wegovy can significantly increase the weight loss effects the drug is known for. Novo Nordisk has announced topline results from the ...

The threat to young puppies and older dogs needs to upgraded by one level compared to the chart. In addition, sick or obese dogs need to have their threat level upgraded by one as well.

Novo Nordisk has commenced the STEP UP and STEP UP T2D trials to explore the efficacy of semaglutide 7.2mg. Credit: © 2025 Novo Nordisk A/S. Novo Nordisk’s high ...

Keeping your dog’s weight in check is critical for their long-term health and activity levels. However, the wide variety of dog food choices may make it difficult to select the right food that ...

Novo Nordisk said that patients taking a higher dose of its blockbuster Wegovy obesity shot lost more weight than those on a lower dose without experiencing an increase in side-effects ...

Novo Nordisk said that patients taking a higher dose of its blockbuster obesity drug Wegovy lost more weight than those on a lower dose without experiencing an increase in side-effects ...

Novo Nordisk said that patients taking a higher dose of its blockbuster Wegovy obesity shot lost more weight than those on a lower dose without experiencing an increase in side effects ...

Semaglutide 7.2 mg achieved 20.7% weight loss at 72 weeks versus 17.5% for 2.4 mg and 2.4% for placebo in the STEP UP trial. 33.2% of participants on 7.2 mg lost ≥25% body weight compared to 16. ...